MSCI ACWI IMI Immuno-Oncology Index

The MSCI ACWI IMI Immuno-oncology Index aims to represent the performance of a set of companies that are associated with research, development, and commercialization of products for cancer immunotherapy, also known as Immuno-oncology. Immuno-oncology is a form of cancer treatment that uses the power of the body’s own immune system to prevent, control and eliminate cancer.
Get in touch
Document downloads
Index code
752570
Index type
Equity
Benchmark administrator
--
Div Yld (%)
2.12
P/E
34.50
P/E Fwd
25.45
P/BV
4.40
Number of constituents
48
Index Market Cap
$2.49 T
Largest constituent Market Cap
$201.81 B
Smallest constituent Market Cap
$1.57 B
Average constituent Market Cap
$52.01 B
Median constituent Market Cap
$23.32 B
Does this benchmark pursue ESG objectives?
No
Data as of Aug. 29, 2025 

Want to learn more about MSCI indexes?
Get in touch.

Contact us